Sorafenib Combined with Transarterial Chemoembolization versus Transarterial Chemoembolization Alone for Advanced-Stage Hepatocellular Carcinoma: A Propensity Score Matching Study

Open Access

Peer-reviewed

Research Article

Hao Hu,

Affiliation Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⨯
Zhenhua Duan,

Affiliation Chengdu Center for Disease Control and Prevention, Chengdu, China
⨯
Xiaoran Long,

Affiliation School of Pharmacy, Anhui Medical University, Hefei, China
⨯
Yancu Hertzanu,

Affiliation Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
⨯
Haibin Shi,

Affiliation Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⨯
Sheng Liu,

Affiliation Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⨯
Zhengqiang Yang

* E-mail: olivialong@sina.cn

Affiliation Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⨯

Reader Comments (0)

Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Portal veins
Is the Subject Area "Portal veins" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Thrombosis
Is the Subject Area "Thrombosis" applicable to this article?

Thanks for your feedback.
Metastatic tumors
Is the Subject Area "Metastatic tumors" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.